NCT01302405View on ClinicalTrials.gov

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2015

Conditions

Advanced Solid Tumors

Interventions

DRUG

PRI-724

Dose escalation

Trial Locations (3)

55901

Mayo Clinic, Department of Oncology, Rochester

90033

University of Southern California, Norris Comprehensive Cancer Center, Los Angeles

85259-5499

Mayo Clinic, Scottsdale

Sponsors

Collaborators (1)

inVentiv Health Clinical

All Listed Sponsors

collaborator

inVentiv Health Clinical

OTHER

lead

Prism Pharma Co., Ltd.

INDUSTRY